Education
About Us
Working with TipRanks
Follow Us
Wai Chun Bio-Technology Ltd. (HK:0660)
:0660
Total Valuation
Wai Chun Bio-Technology Ltd. has a market cap or net worth of HK$34.27M. The enterprise value is HK$141.69M.
Market CapHK$34.27M
Enterprise ValueHK$141.69M
Share Statistics
Wai Chun Bio-Technology Ltd. has 178,476,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding178,476,460
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Wai Chun Bio-Technology Ltd.’s return on equity (ROE) is 0.44 and return on invested capital (ROIC) is 18.15%.
Return on Equity (ROE)0.44
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)18.15%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee6.29M
Profits Per Employee-125.47K
Employee Count123
Asset Turnover3.22
Inventory Turnover19.25
Valuation Ratios
The current PE Ratio of Wai Chun Bio-Technology Ltd. is ―. Wai Chun Bio-Technology Ltd.’s PEG ratio is -0.17.
PE Ratio―
PS Ratio0.02
PB Ratio-0.49
Price to Fair Value-0.49
Price to FCF1.00
Price to Operating Cash Flow0.73
PEG Ratio-0.17
Income Statement
In the last 12 months, Wai Chun Bio-Technology Ltd. had revenue of 773.65M and earned -15.43M in profits. Earnings per share was -0.09.
Revenue773.65M
Gross Profit50.41M
Operating Income14.89M
Pretax Income-5.70M
Net Income-15.43M
EBITDA14.89M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was 58.21M and capital expenditures -50.26M, giving a free cash flow of 7.95M billion.
Operating Cash Flow58.21M
Free Cash Flow7.95M
Free Cash Flow per Share0.04
Dividends & Yields
Wai Chun Bio-Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change171.43%
50-Day Moving Average0.20
200-Day Moving Average0.15
Relative Strength Index (RSI)42.84
Average Volume (3m)83.65K
Important Dates
Wai Chun Bio-Technology Ltd. upcoming earnings date is Aug 28, 2026, TBA (Confirmed).
Last Earnings DateSep 30, 2025
Next Earnings DateAug 28, 2026
Ex-Dividend Date―
Financial Position
Wai Chun Bio-Technology Ltd. as a current ratio of 0.81, with Debt / Equity ratio of -383.76%
Current Ratio0.81
Quick Ratio0.58
Debt to Market Cap7.80
Net Debt to EBITDA8.60
Interest Coverage Ratio0.87
Taxes
In the past 12 months, Wai Chun Bio-Technology Ltd. has paid 4.36M in taxes.
Income Tax4.36M
Effective Tax Rate-0.77
Enterprise Valuation
Wai Chun Bio-Technology Ltd. EV to EBITDA ratio is 9.75, with an EV/FCF ratio of 8.43.
EV to Sales0.19
EV to EBITDA9.75
EV to Free Cash Flow8.43
EV to Operating Cash Flow3.20
Balance Sheet
Wai Chun Bio-Technology Ltd. has HK$5.43M in cash and marketable securities with HK$137.55M in debt, giving a net cash position of -HK$132.11M billion.
Cash & Marketable SecuritiesHK$5.43M
Total DebtHK$137.55M
Net Cash-HK$132.11M
Net Cash Per Share-HK$0.74
Tangible Book Value Per ShareHK$0.06
Margins
Gross margin is 6.52%, with operating margin of 1.93%, and net profit margin of -1.99%.
Gross Margin6.52%
Operating Margin1.93%
Pretax Margin-0.74%
Net Profit Margin-1.99%
EBITDA Margin1.93%
EBIT Margin0.00%
Analyst Forecast
The average price target for Wai Chun Bio-Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―